About N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide
N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide (PubChem CID 158664069) has the molecular formula C29H32Br2Cl2N4O2
and a molecular weight of 699.32 g/mol. Its IUPAC name is N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide.
Molecular Properties
| Compound Name | N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide |
| PubChem CID | 158664069 |
| Molecular Formula | C29H32Br2Cl2N4O2 |
| Molecular Weight | 699.32 g/mol |
| Exact Mass | 696.03 |
| IUPAC Name | N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide |
| SMILES | Br.Br.[H]/N=c1\n(CC(=O)c2ccc(Cl)cc2Cl)c2cccc(CC)c2n1CCCN(C)C(=O)Cc1ccccc1 |
| InChI | InChI=1S/C29H30Cl2N4O2.2BrH/c1-3-21-11-7-12-25-28(21)34(16-8-15-33(2)27(37)17-20-9-5-4-6-10-20)29(32)35(25)19-26(36)23-14-13-22(30)18-24(23)31;;/h4-7,9-14,18,32H,3,8,15-17,19H2,1-2H3;2*1H/b32-29-;; |
| InChIKey | VAICPNLOMUGENY-ZFFKAUIFSA-N |
| XLogP | 6.92 |
| TPSA | 71.09 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 699.32 |
| LogP ≤ 5 | 6.92 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Analyze N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide?
The IUPAC name of N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide (CID 158664069) is N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide.
What is the SMILES notation for N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide?
The canonical SMILES for N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide is Br.Br.[H]/N=c1\n(CC(=O)c2ccc(Cl)cc2Cl)c2cccc(CC)c2n1CCCN(C)C(=O)Cc1ccccc1.
What is the InChIKey of N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide?
The InChIKey is VAICPNLOMUGENY-ZFFKAUIFSA-N. The full InChI is InChI=1S/C29H30Cl2N4O2.2BrH/c1-3-21-11-7-12-25-28(21)34(16-8-15-33(2)27(37)17-20-9-5-4-6-10-20)29(32)35(25)19-26(36)23-14-13-22(30)18-24(23)31;;/h4-7,9-14,18,32H,3,8,15-17,19H2,1-2H3;2*1H/b32-29-;;.
What are the key properties of N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide?
N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide has a molecular weight of 699.32 g/mol, XLogP of 6.92, 10 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[3-[2-(2,4-dichlorophenyl)-2-oxoethyl]-7-ethyl-2-iminobenzimidazol-1-yl]propyl]-N-methyl-2-phenylacetamide;dihydrobromide is sourced from PubChem (CID 158664069), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).